Enzo Biochem, Inc. And Enzo Clinical Laboratories Pay $3.5 Million To Resolve Civil Fraud Allegations
U.S. Attorney Loretta E. Lynch today announced that the United States and New York State have entered into a settlement agreement with Enzo Biochem, Inc., and one of its subsidiaries, Enzo Clinical Laboratories (collectively, "Enzo"), to resolve a case brought under the federal False Claims Act and the New York False Claims Act. The matter involves allegations that Enzo wrongfully input diagnosis codes into claim forms that it submitted for payment to the Centers for Medicare & Medicaid Services ("CMS"). Under the terms of the Settlement Agreement, Enzo will pay a total of $3,510,245.94 to resolve the investigation.
- Date:September 24, 2014
- Agency:U.S. Attorney
- Criminal and Civil Actions